Table 1.
Correlation of TSP50 protein expression with clinicopathological parameters.
| Patients features | All cases | TSP50 protein expression | ||
|---|---|---|---|---|
| High expression | Low expression | P valuea | ||
| Gender | ||||
| Male | 233 | 138 (59.2%) | 95 (40.8%) | 0.252 |
| Female | 101 | 53 (52.5%) | 48 (47.5%) | |
| Age at surgery | ||||
| ≥57b | 172 | 84 (48.8%) | 88 (51.2%) | 0.001 |
| <57 | 162 | 107 (66.0%) | 55 (34.0%) | |
| Tumor size | ||||
| ≥5 cm | 149 | 84 (56.4%) | 65 (43.6%) | 0.788 |
| <5 cm | 185 | 107 (57.8%) | 78 (42.2%) | |
| Histological type | ||||
| Intestinal | 265 | 142 (53.6%) | 99 (46.4%) | 0.582 |
| Diffuse | 69 | 38 (55.1%) | 31 (44.9%) | |
| TNM | ||||
| I + II | 117 | 49 (41.9%) | 68 (58.1%) | 0.000 |
| III + IV | 217 | 142 (65.4%) | 75 (34.6%) | |
| Lymph node metastases | ||||
| Present | 234 | 146 (62.4%) | 88 (37.6%) | 0.003 |
| Absent | 100 | 45 (45.0%) | 55 (55.0%) | |
aChi square test; bmedian age.